期刊文献+

替吉奥联合奥沙利铂治疗老年人晚期胃癌疗效观察 被引量:3

下载PDF
导出
摘要 胃癌是我国常见的恶性肿瘤之一。随着我国老龄化社会的到来,老年人胃癌日益增多,在全球新发胃癌病例中42%的病例发生在中国^[1],因早期患者常无明显特异症状,在确诊时,约50%胃癌患者肿瘤已无法切除,发生局部进展或转移。因此化疗是主要的治疗手段^[2],胃癌为化疗中度敏感肿瘤,通过化疗可以延长患者生存期^[3]。
作者 孙宏劭 杨艳
出处 《武警医学》 CAS 2012年第3期253-254,共2页 Medical Journal of the Chinese People's Armed Police Force
  • 相关文献

参考文献11

  • 1Parkin D M,Bray F,Ferlay J,et al.Global cancer statistics[J].CA Cancer J Clin,2005,55﹙2﹚:74.
  • 2Mizoshita T,Kataoka H,Kubota E,et al.Gastricphenotype signe-tring cell carcinoma of the stomach with multiple bone metastaseseffectively treated with sequential meth-otrexate and 5-fluorou-racil[J].Int J Clin Oncol,2008,13﹙4﹚:373.
  • 3Glimelius B,Ekstrom K,Hoffman K,et al.Randomized comparisonbetween chemotherapy plus best supportive care with best support-ive care in advanced gastric cancer[J].Ann Oncol,1997,8(2):163-168.
  • 4Alberts S R,Cervantes A,VANDE Velde C J,et al.Gastric canc-er:epidemiology,pathology and treatment[J].Ann Oncol,2003,14(suppl 2):S31.
  • 5Sato A,Ito T,Tomita T.Chemotherapy of gastric cancer-a reviewof clinical trials in Japan 2002[J].Gan To Kaggku Ryobo,2002,29﹙9﹚:1522.
  • 6白坂哲彦 佃守犬山 夫他新规.经口抗癌剂TS-1(S-1).癌症化学疗法,2001,:855-864.
  • 7Koizumi W,Akiya T,Sato A,et al.PhaseⅡstudy of S-1 asfirst-line treatment for elderly patients over 75 years of age withadvanced gastric cancer:the Tokyo Cooperative Oncology Groupstudy[J].Cancer Chemother Pharmacol,2010,65(6):1093-1099.
  • 8Koizumi W.S-1 plus cisplatin versus S-1 alone for first-linetreatment of advanced gastric cancer.(SPIRITS trial):a phase IIItrial[J].Lancet Oncol,2008,9(3):215.
  • 9Boku N.Chemotherapy for metastatic disease:review from JCOGtrial[J].International Journal of Clinical Oncology,2008,13(3):196.
  • 10Al Batran S E,Atmaca A,Hegewisch-Becker S,et al.Phase IItrial of biweekly infusional fluorouracil,folinic acid,and oxalipla-tin in patients with advanced gastric cancer[J].J Clin Oncol,2004;22:658-663.

二级参考文献7

共引文献8

同被引文献29

  • 1孙燕.临床肿瘤内科手册[M].5版.北京:人民卫生出版社,2008:597.
  • 2周际昌.实用肿瘤内科学[M].3版.北京:人民卫生出版社,1997:23-35,286-289.
  • 3陆舜.S-1治疗晚期非小细胞肺癌:一种独特的口服氟尿嘧啶类药物[J].肿瘤时讯,2010,7:5-7.
  • 4Gridelli C, Langer G, Maione P, et al. Lung cancer in the elderly [ J ]. J Clin Oneol, 2007,25 ( 14 ) : 1898-1907.
  • 5Hoshino S, Sugano T, Kitamura T, et al. A case report of S-1 single effective use as third-line chemotherapy and re-challenge in a recurrent squamous cell lung cancer pa- tient[ J]. Gan To Kagaku Ryoho, 2005,35 (7) : 1181- 1184.
  • 6Katayama T, Watari M. An advanced aged case of in- trapulmonary metastasis of non-small cell lung cancer sue- cessfully controlled with S-1 capsule therapy alone for an extended period [ J ]. Gan To Kagaku Ryoho, 2007,34 (5) :753-756.
  • 7Totani Y, Saito Y, Hayashi M, et al. A phase II study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancer [ J ]. Cancer Chemother Phar- maeol, 2009,64(6) :1181-1185.
  • 8Takiguchi Y, Tade Y, Gemma A, et al. Phase I/II study of doeetaxel and S-l, an oral fluorinated pyrimi- dine, for untreated advaneed non-small cell lung cancer [J]. Lung Cancer, 2010,68(3) :409-414.
  • 9Yumine K, Kawahara M. Phase II study of S-1, a noval oral fluorouracil, in advanced non-small cell lung cancer [J]. Gan To Kagaku Ryoho, 2006,33 (Suppl 1 ) : 189- 192.
  • 10Ono A, Naito T, Murakami H, et al. Evaluation of S-1 as third-or further-line chemotherapy in advanced non- small-cell lung cancer [ J ]. Int J Clin Oncol, 2010,15 (2) :161-165.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部